The Philadelphia Phillies' bullpen has been a mixed bag in 2025, with two distinct units emerging at different points in the season. The team's early-season bullpen was marked by inconsistency and poor performances from pitchers such as Jordan Romano, while the late-inning relief corps, led by Jhoan Duran, was much more effective.
Duran, who was acquired at the trade deadline, was a dominant force in the Phillies' bullpen, boasting a lights-out 3.75 ERA and 10.2 strikeouts per nine innings. He will return for another season under contract through 2028.
Several other key relievers are expected to be back with the team next year, including Orion Kerkering, Tanner Banks, Matt Strahm, and Max Lazar. Kerkering, a late-inning righty, will look to bounce back from an errant postseason throw in the playoffs, while Banks, a left-handed specialist, is under team control until 2029.
The Phillies are also expected to re-sign Matt Strahm, who had his option exercised for 2026. Lazar, meanwhile, may not make the team out of spring training if the Phillies add free agent relievers, but he has minor league options and could be a useful asset in the bullpen.
However, two key players will likely be decided on as free agents: José Alvarado and David Robertson. Alvarado, who was the team's best reliever early in the season before serving an 80-game suspension for steroid use, will have a $9 million team option with a $500,000 buyout. The Phillies may decide to re-sign him, but his off-field issues are a significant concern.
Robertson, meanwhile, returns from another stint with the team and pitched decently over 17.2 innings in the postseason. However, he will be 41 next season, which makes it unlikely that the Phillies will want to keep him on at such a high price.
The other relievers on the list include Seth Johnson, Tim Mayza, Lou Trivino, Jordan Romano, and Joe Ross, but all of these players have already been largely written off for next year due to poor performances.
Overall, the Phillies' bullpen is likely to be improved in 2026, with Duran and several other key pitchers returning. However, Alvarado's suspension and Robertson's age may make it a challenge to keep both of them on the roster.
Duran, who was acquired at the trade deadline, was a dominant force in the Phillies' bullpen, boasting a lights-out 3.75 ERA and 10.2 strikeouts per nine innings. He will return for another season under contract through 2028.
Several other key relievers are expected to be back with the team next year, including Orion Kerkering, Tanner Banks, Matt Strahm, and Max Lazar. Kerkering, a late-inning righty, will look to bounce back from an errant postseason throw in the playoffs, while Banks, a left-handed specialist, is under team control until 2029.
The Phillies are also expected to re-sign Matt Strahm, who had his option exercised for 2026. Lazar, meanwhile, may not make the team out of spring training if the Phillies add free agent relievers, but he has minor league options and could be a useful asset in the bullpen.
However, two key players will likely be decided on as free agents: José Alvarado and David Robertson. Alvarado, who was the team's best reliever early in the season before serving an 80-game suspension for steroid use, will have a $9 million team option with a $500,000 buyout. The Phillies may decide to re-sign him, but his off-field issues are a significant concern.
Robertson, meanwhile, returns from another stint with the team and pitched decently over 17.2 innings in the postseason. However, he will be 41 next season, which makes it unlikely that the Phillies will want to keep him on at such a high price.
The other relievers on the list include Seth Johnson, Tim Mayza, Lou Trivino, Jordan Romano, and Joe Ross, but all of these players have already been largely written off for next year due to poor performances.
Overall, the Phillies' bullpen is likely to be improved in 2026, with Duran and several other key pitchers returning. However, Alvarado's suspension and Robertson's age may make it a challenge to keep both of them on the roster.